Because of the known role of mutant GARS in mediating sensory neuron pathology in CMT2D, our findings provide experimental evidence of a significant molecular and phenotypic overlap between SMA and CMT. This evidence concerns the gene GARS1 and proximal spinal muscular atrophy.